Publication | Closed Access

Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial

VaccinationGranulocyteHuman RetrovirusImmunologyAntiviral ResponsePhase 1B/2aChronic Viral InfectionHivMedicineHiv-1 ReservoirCombined EffectPhagocyte